In the whole tumor cell population recurrent mutations were observed at the level of TP53 (64%), PIK3CA/PIK3R1 (61%), RAS/MAP kinase (25%), and TERT (25%) mutations [246]. The gene discussed is TP53; the disease is neoplasm.